FibroGen, Inc (FGEN): Price and Financial Metrics


FibroGen, Inc (FGEN): $25.82

-0.24 (-0.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 487

in industry

FGEN POWR Grades


  • FGEN scores best on the Growth dimension, with a Growth rank ahead of 88.41% of US stocks.
  • FGEN's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • FGEN ranks lowest in Momentum; there it ranks in the 5th percentile.

FGEN Stock Summary

  • Of note is the ratio of Fibrogen Inc's sales and general administrative expense to its total operating expenses; just 11.84% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Fibrogen Inc is higher than it is for about just 12.21% of US stocks.
  • Revenue growth over the past 12 months for Fibrogen Inc comes in at -25.97%, a number that bests just 15.19% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Fibrogen Inc are CUE, ARVN, ACRS, APTX, and ARLO.
  • Visit FGEN's SEC page to see the company's official filings. To visit the company's web site, go to www.fibrogen.com.

FGEN Price Target

For more insight on analysts targets of FGEN, see our FGEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $40.57 Average Broker Recommendation 1.75 (Moderate Buy)

FGEN Stock Price Chart Interactive Chart >

Price chart for FGEN

FGEN Price/Volume Stats

Current price $25.82 52-week high $57.21
Prev. close $26.06 52-week low $18.12
Day low $25.43 Volume 844,500
Day high $26.51 Avg. volume 1,276,245
50-day MA $21.79 Dividend yield N/A
200-day MA $37.25 Market Cap 2.38B

FibroGen, Inc (FGEN) Company Bio


Fibrogen is a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. The company was incorporated in 1993 and is based in San Francisco, California.


FGEN Latest News Stream


Event/Time News Detail
Loading, please wait...

FGEN Latest Social Stream


Loading social stream, please wait...

View Full FGEN Social Stream

Latest FGEN News From Around the Web

Below are the latest news stories about Fibrogen Inc that investors may wish to consider to help them evaluate FGEN as an investment opportunity.

FGEN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of June 11, 2021 in the Class Action Filed on Behalf of FibroGen, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - June 10, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging that the Company violated federal securities laws.Class Period: October 18, 2017 and April 6, 2021Lead Plaintiff Deadline: June 11, 2021Learn more about your recoverable losses in FGEN:http://www.kleinstocklaw.com/pslra-1/fibrogen-inc-loss-submission-form?id=16783&from=5The filed complaint alleges that

Yahoo | June 10, 2021

FINAL DEADLINE FRIDAY: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 10, 2021 / The Schall Law Firm has filed a securities class action lawsuit on behalf of plaintiff Thomas Leonard against FibroGen, Inc. ('FibroGen' or the 'Company') (NASDAQ:FGEN) and certain of its officers, which expands the class period.

Yahoo | June 10, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of FibroGen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 11, 2021 - FGEN

New York, New York--(Newsfile Corp. - June 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of FibroGen, Inc. ("FibroGen") (NASDAQ: FGEN) between October 18, 2017 and April 6, 2021. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Middle District of North Carolina. To get more ...

Yahoo | June 10, 2021

FINAL DEADLINE TOMORROW: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

The Schall Law Firm announced today that they have filed a securities class action lawsuit on behalf of plaintiff Thomas Leonard against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of its officers, which expands the class period. The class action is on behalf of a class consisting of investors who purchased or otherwise acquired FibroGen securities between October 18, 2017 and April 6, 2021, inclusive (the "Class Period"). Plaintiff seeks to recover compensable damage

Yahoo | June 10, 2021

DEADLINE TOMORROW: The Schall Law Firm Files Securities Class Action Suit with Extended Class Period Against FibroGen, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - June 10, 2021) - The Schall Law Firm announced today that they have filed a securities class action lawsuit on behalf of plaintiff Thomas Leonard against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of its officers, which expands the class period. The class action is on behalf of a class consisting of investors who purchased or otherwise acquired FibroGen securities between October 18, 2017 and April ...

Yahoo | June 10, 2021

Read More 'FGEN' Stories Here

FGEN Price Returns

1-mo 19.76%
3-mo -23.20%
6-mo -41.64%
1-year -34.42%
3-year -56.13%
5-year 58.31%
YTD -30.39%
2020 -13.52%
2019 -7.32%
2018 -2.36%
2017 121.50%
2016 -29.77%

Continue Researching FGEN

Here are a few links from around the web to help you further your research on Fibrogen Inc's stock as an investment opportunity:

Fibrogen Inc (FGEN) Stock Price | Nasdaq
Fibrogen Inc (FGEN) Stock Quote, History and News - Yahoo Finance
Fibrogen Inc (FGEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8054 seconds.